CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Financial Officer sold 794 shares at $6.52 ($5,177)
- 4 Open-market sale Chief Legal Officer sold 332 shares at $6.52 ($2,165)
- 4 Open-market sale Chief Business & Strategy Ofcr sold 652 shares at $6.52 ($4,251)
- 4 Open-market sale Chief Scientific Officer sold 629 shares at $6.52 ($4,101)
- 4 Open-market sale Chief Medical Officer sold 593 shares at $6.52 ($3,866)
- 4 Open-market sale Chief Development Officer sold 623 shares at $6.52 ($4,062)
- 4 Open-market buy Director bought 986,721 shares at an average $10.87 ($10,726,255)
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Financial Officer sold 3,282 shares at $26.37 ($86,546)
- 4 Open-market sale Chief Legal Officer sold 1,364 shares at $26.37 ($35,969)
- 4 Open-market sale Chief Business & Strategy Ofcr sold 2,692 shares at $26.37 ($70,988)
- 4 Open-market sale Chief Scientific Officer sold 2,596 shares at $26.37 ($68,457)
- 4 Open-market sale Chief Medical Officer sold 2,447 shares at $26.37 ($64,527)
Page 1 of 13 · 250 filings